Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;36(6):718-725.
doi: 10.1111/dme.13825. Epub 2018 Oct 10.

Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis

Affiliations

Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis

S McGurnaghan et al. Diabet Med. 2019 Jun.

Abstract

Aims: To describe the prevalence of major cardiovascular disease (CVD) and risk factor control in a contemporary population with Type 2 diabetes.

Methods: We used data from the national registry in Scotland, Scottish Care Information-Diabetes, linked to hospital admissions. Using descriptive statistics and logistic regression we described associations of risk factors with CVD. CVD was defined based on diagnostic codes in primary or secondary care data for ischaemic heart disease, cerebrovascular disease peripheral arterial disease, heart failure, cardiac arrhythmia, hypertensive heart disease and revascularization procedures.

Results: Among 248 400 people with Type 2 diabetes with a median age of 67.5 years (IQR 58.2, 76.1) and median diabetes duration of 7.8 years (3.8, 13.0), 32% had prior CVD (35% of men, 29% of women). Median HbA1c overall was 55 mmol/mol (7.2%), median SBP was 132 mmHg, median total cholesterol was 4.1 mmol/l and mean BMI was 32 kg/m2 . Overall two-thirds (65% of men, 68% of women) have two or more of the following CVD risk factor thresholds: HbA1c ≥ 53 mmol/mol (7%), SBP > 130 mmHg or DBP > 80 mmHg, total cholesterol ≥ 5 mmol/l or BMI ≥ 30 kg/m2 , or were currently smoking. Overall 84% were taking anti-hypertensives and 75% a statin. Use of metformin was common at 58%, but other diabetes drugs that reduce CVD were rarely used.

Conclusions: There continues to be a high prevalence of CVD among people with Type 2 diabetes and a high level of unmet need for risk factor control. This implies substantial scope for reducing the excess risk of CVD in diabetes through improved management of known risk factors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Statin and anti‐hypertensive use by risk factor threshold and cardiovascular disease (CVD) status.

References

    1. Read SH, Kerssens JJ, McAllister DA, Colhoun HM, Fischbacher CM, Lindsay RS et al Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. Diabetologia 2016; 59: 2106–2113. - PMC - PubMed
    1. Read SH, McAllister DA, Colhoun HM, Farran B, Fischbacher C, Kerssens JJ et al Incident ischaemic stroke and Type 2 diabetes: trends in incidence and case fatality in Scotland 2004–2013. Diabet Med 2018; 35: 99–106. - PubMed
    1. Rawshani A, Rawshani A, Gudbjörnsdottir S. Mortality and cardiovascular disease in Type 1 and Type 2 diabetes. N Engl J Med 2017; 377: 300–301. - PubMed
    1. Burrows NR, Li Y, Gregg EW, Geiss LS. Declining rates of hospitalization for selected cardiovascular disease conditions among adults aged ≥35 years with diagnosed diabetes, U.S., 1998–2014. Diabetes Care 2018; 41: 293–302. - PMC - PubMed
    1. National Institute of Health and Care Excellence (NICE) . Type 2 Diabetes in Adults: Management. NG28. Available from https://www.nice.org.uk/guidance/ng28 Last accessed 28 February 2018.

Publication types